NORML Launches Survey Measuring Consumer 'Freedom' Beyond Legal Status

NORML has opened its 2026 Cannabis Freedom Survey, a one-minute questionnaire designed to measure how cannabis consumers actually experience freedom—not just what state statutes permit on paper.

The advocacy organization says the survey aims to capture the gap between legal reform and lived reality. While 38 states now allow some form of cannabis use, consumers still face employment discrimination, housing restrictions, and social stigma that laws don't address.

"We know the law books and we know the ballot measures," said Paul Armentano, NORML's deputy director, in announcing the survey. "What we need to understand better is how those legal changes translate—or don't translate—into actual day-to-day freedom for consumers."

The survey arrives as the cannabis reform movement enters what some advocates call a "post-legalization" phase. After decades focused on changing criminal statutes, organizations like NORML are pivoting to questions of equity, access, and normalization.

What the Survey Measures

Questions reportedly cover workplace policies, landlord attitudes, family dynamics, and medical access. The survey also asks about consumption locations, social acceptance, and whether respondents feel they can discuss cannabis use openly.

NORML plans to use the data for legislative advocacy and public education campaigns. Previous consumer surveys from the organization have informed testimony before state legislatures and federal agencies.

The timing coincides with several states considering workplace protection bills. New York, New Jersey, and Connecticut already prohibit most employers from discriminating based on off-duty cannabis use. But in states like Florida and Ohio—both with active medical programs—workers can still be fired for testing positive.

The Freedom Gap

Industry observers note that legal cannabis hasn't eliminated the "freedom gap" advocates identify. Banking restrictions persist under federal prohibition. Parents in legal states still lose custody battles over cannabis use. Medical patients face insurance complications and interstate travel restrictions.

"You can walk into a dispensary in Colorado and buy an ounce, then get evicted from federal housing for having it," noted one consumer advocate. "That's the disconnect NORML is trying to quantify."

The survey also arrives amid renewed federal scheduling debates. The DEA's proposed move of cannabis to Schedule III would maintain criminal penalties while acknowledging medical value—a shift that might not change consumer freedoms significantly.

What Happens Next

NORML says it will release survey results in late 2026, likely timed to congressional committee hearings on cannabis policy. The organization has committed to publishing raw data alongside analysis.

Participation is anonymous and open to any U.S. adult, regardless of cannabis use status. The survey asks respondents to identify their state and legal status (medical patient, adult-use consumer, non-user, etc.).

For an advocacy organization that helped drive legalization in 24 states, the survey represents a strategic evolution. The question is no longer just "Can you legally buy cannabis?" but "Does legal cannabis actually make you free?"

The survey remains open through December 2026. NORML says early response has been strong, with particular interest from consumers in newly legal states like Ohio and from medical patients in restrictive programs.

---

This article is based on original reporting by hightimes.com.